logo
Select company
Select metric
$ -22.07MEarning Before Interest & Taxes (EBIT)
VS
Market
24
Sector
51
Industry
65
History
29
$ 6.09Close
$ 4.52 - $ 10.98 52-Week Range
Ticker Information

Ticker

NVCT

Company Name

NUVECTIS PHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NUVECTIS PHARMA INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NVCT - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -22.07M
3/31/2025$ -20.16M
12/31/2024$ -19M
9/30/2024$ -19.37M
6/30/2024$ -21.1M
3/31/2024$ -22.38M
12/31/2023$ -22.26M
9/30/2023$ -22.33M
6/30/2023$ -22.33M
3/31/2023$ -20.19M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NUVECTIS PHARMA INC's latest trailing twelve months (TTM) EBIT stands at $ -10K.
  • Over the past 5 years, NUVECTIS PHARMA INC's average EBIT has been $ -18.09M.
  • The median EBIT for NUVECTIS PHARMA INC during this period was $ -20.16M
  • NUVECTIS PHARMA INC reached its highest EBIT over the past 5 years at $ -10K.
  • The lowest EBIT recorded by NUVECTIS PHARMA INC in the same timeframe $ -22.38M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

NVCT - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -22.38M

Minimum

Mar 31, 2024

$ -10K

Maximum

Dec 31, 2020

$ -18.09M

Average

$ -20.16M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.64M with a standard deviation of $ 130.66M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.64M
median$ 897.02K
std$ 130.66M